Announced Mon, 20 Jul · 20:02 IST
Q1 FY27 results: revenue up 11%, PAT up 14%; board approves director continuation
Management Changes View source PDF
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-16.9%1-day move
₹391.00
prior close
₹390.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.7-5.1-4.7-4.9-16.9-18.7-17.1-18.2——————
Up moveDown movePending
AI summary
Bajaj Healthcare posted Q1 FY27 revenue of Rs 16,563 lakhs, up 11% year on year from Rs 14,884 lakhs. Profit after tax from continuing operations rose to Rs 1,389 lakhs vs Rs 1,217 lakhs. Basic EPS stood at Rs 4.07 vs Rs 3.74. Discontinued operations reported a loss of Rs 19 lakhs. Board approved continuation of independent director Gopalakrishnan Kesavan beyond age 75, subject to shareholder approval. Listing approvals received for 20.79 lakh shares from earlier warrant conversion.
Likely market impact
Steady revenue and profit growth; no major governance change. Watch discontinued ops and pending Genrx acquisition.